Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.
BKEVER 試驗的見解:比較 everolimus 與 mycophenolate mofetil 在腎臟移植受者中對 BK Polyomavirus 感染的療效。
Kidney Int 2024-11-04
A sub-study of the POISE-3 randomized trial examined effects of a perioperative hypotension-avoidance strategy versus a hypertension-avoidance strategy on the risk of acute kidney injury.
POISE-3 隨機試驗的子研究探討了圍手術期避免低血壓策略與避免高血壓策略對急性腎損傷風險的影響。
Kidney Int 2024-11-04
在POISE-3試驗的子研究中,研究人員探討了兩種圍手術期策略對7307名高風險患者術後急性腎損傷(AKI)風險的影響。避免低血壓的策略目標是維持平均動脈壓(MAP)在80 mm Hg以上,而避免高血壓則是保持MAP在60 mm Hg以上。結果顯示,雖然避免低血壓組使用的降壓藥物較少,且低於80 mm Hg的時間也較短,但兩組的AKI風險並無顯著差異(分別為15.1%和14.4%)。因此,避免低血壓的策略並未降低AKI風險。
相關文章PubMedDOI
Higher intraoperative blood pressure does not reduce acute kidney injury in non-cardiac surgery: what do the results of the POISE-3 trial tell us?
非心臟手術中較高的術中血壓並不減少急性腎損傷:POISE-3 試驗的結果告訴我們什麼?
Kidney Int 2024-11-04
Avoiding Arrythmias by Personalizing Dialysate Concentration: A Case for Precision Medicine in Dialysis Patients.
透析液濃度個性化以避免心律不整:透析患者精準醫療的案例。
Kidney Int 2024-11-03
Effects of dialysate potassium concentration of 3.0mEq/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0mEq/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.
高鉀血症血液透析患者中,使用3.0mEq/l的透析液鉀濃度搭配鈉鋯環矽酸鹽對無透析日數的影響與單獨使用2.0mEq/l的透析液鉀濃度對心臟心律不整發生率的比較。
Kidney Int 2024-11-03
Premature mortality and disparities in kidney healthcare for people with chronic kidney disease and severe mental health difficulties.
慢性腎病及重度心理健康困難患者的早逝與腎臟醫療差異。
J Nephrol 2024-11-02
Prevalence and associated factors of acute kidney injury in Ethiopia, systematic review and meta-analysis.
埃塞俄比亞急性腎損傷的流行率及相關因素:系統性回顧與統合分析。
J Nephrol 2024-11-01